GlassScriptPhysician profile
Caryn A Bowden
NPI 1508923368
$872.44
in general payments reported to CMS, 2019-2025
12 companies · $58.30 in 2025
The $58.30 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $268 · 2022: $144 · 2023: $234 · 2024: $168 · 2025: $58.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $309.04 | 2021-2025 | Otezla, Repatha, Repatha |
| Novo Nordisk INC | $291.19 | 2021-2024 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $96.61 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $33.86 | 2021 | |
| Amarin Pharma, INC. | $33.56 | 2021 | |
| Organon LLC | $25.71 | 2025 | Nexplanon |
| Pfizer INC. | $17.08 | 2024 | |
| Cranial Technologies, INC | $15.21 | 2025 | Doc Band |
| Boston Scientific Corporation | $13.15 | 2024 | Orcapod |
| Abbott Laboratories | $13.06 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.34 | 2022 | |
| Neos Therapeutics, LP | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caryn Bowden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.